PEG-MGF 2MG
$159.00
PEG-MGF 2MG is a pegylated form of Mechano Growth Factor, a splice variant of IGF-1 with a sequence distinct from liver-derived systemic IGF-1. The PEG modification enhances stability and extends functional persistence, making it suitable for controlled laboratory research.
Researchers study PEG-MGF to explore growth factor signaling and cellular responses related to mechanical stress. Supplied as a high-purity lyophilized powder, it is intended exclusively for in vitro and laboratory research applications and not for human or veterinary use.
Description
PEG-MGF 2MG is Pegylated Mechano Growth Factor. It is a long-acting variant of MGF which is a split variant of IGF-1 (but its sequence differs from the systemic IGF-1 produced by the liver).
Chemical Information
- Chemical Name: PEGylated Mechano Growth Factor (PEG-MGF)
- Molecular Formula: — (PEGylated peptide; exact formula varies by PEG size and salt form)
- Molecular Weight: ~5,000–6,000 Da (approximate; depends on PEG moiety)
- Peptide Length: 24 amino acids (MGF core peptide)
- Classification: Synthetic PEGylated growth factor peptide (IGF-1 splice variant)
- Purity: ≥99% (HPLC, research grade)
- Appearance: White to off-white lyophilized powder
- Net Content: 2 mg
Additional Information
- Sequence Description: PEGylated form of Mechano Growth Factor designed to enhance stability and extend functional persistence in research settings
- CAS Number: Not universally assigned (research peptide)
- Salt Form: Typically acetate or TFA (manufacturer dependent)
- Modification: Polyethylene glycol (PEG) conjugation
Storage Conditions
- Store lyophilized powder at –20 °C or below
- Protect from light, heat, and moisture
- Avoid repeated freeze–thaw cycles after reconstitution
Intended Use
- For research use only (RUO)
- Intended for in vitro and laboratory research applications
- Not for human or veterinary use
Additional information
| Size |
1MG (1000MCG) ,2MG (2000MCG) |
|---|
Reviews (0)
Related products
Acetic Acid .6% 10ML
Acetic Acid 0.6% Solution (10 mL) is supplied in a glass vial and prepared as a clear, dilute aqueous solution. It is commonly used in laboratory settings for the reconstitution of peptides such as AOD9604, IGF-LR3, PEG-MGF, and MGF, and may also benefit other peptides where mild acidity supports stability.
The solution contains acetic acid diluted to 0.6% w/v (6 mg/mL) with an approximate pH of 3. It is produced from analytical-grade acetic acid and intended strictly for laboratory and experimental use only. The vial should be stored at room temperature in a tightly closed container and is not approved for human or veterinary administration.
CJC-1295 (no DAC) 5MG
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic growth hormone-releasing hormone (GHRH) analogue used in laboratory research. It is supplied as a white to off-white lyophilized powder, typically in a 5 mg vial, with high purity (≥98 % HPLC verified) and is intended strictly for research use only.
Unlike DAC-modified versions, CJC-1295 without DAC has a shorter half-life, making it useful for studying pulsatile growth hormone release and receptor activity in controlled preclinical and experimental settings.
DSIP 5MG
Delta Sleep-Inducing Peptide (DSIP) 5MG is a synthetic neuropeptide studied for its role in sleep regulation, particularly slow-wave (deep) sleep. It is supplied as a white to off-white lyophilized powder with ≥99% research-grade purity and a molecular formula of C₃₅H₄₈N₁₀O₁₅.
DSIP has been investigated for its involvement in promoting restorative sleep processes and neuroendocrine balance. Please note that only the 5MG strength is currently available, as the 10MG formulation is no longer being stocked.
FOXO4-DRI
FOXO4-DRI (FOXO4 D-Retro-Inverso Peptide) is a synthetic research peptide composed of 27 D-amino acids with an approximate molecular weight of 5,350–5,400 Da and ≥99% purity. It is supplied as a white to off-white lyophilized powder in 5 mg or 10 mg quantities for laboratory research use.
Researchers use FOXO4-DRI to study cellular aging by examining the selective removal of senescent cells and its impact on tissue repair, regeneration, and longevity pathways through FOXO4–p53 interactions.
GHK-CU 100MG
GHK-Cu (Copper Tripeptide-1) is a synthetic copper peptide complex composed of three amino acids (Gly–His–Lys) bound to copper (II), with a molecular weight of approximately 401.9 Da. It is supplied as a blue to blue-green lyophilized powder with ≥99% research-grade purity and a net content of 100 mg.
GHK-Cu is a naturally occurring copper polypeptide found in blood plasma and saliva and is provided strictly for research use only (RUO). It is not intended for human or veterinary use.
GHRP-6 5MG
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic met-enkephalin analog containing unnatural D-amino acids and composed of six amino acids, with a molecular weight of approximately 873.0 Da. It is classified as a synthetic growth hormone secretagogue (GHS) and is supplied as a white to off-white lyophilized powder with ≥99% HPLC research-grade purity in 5 mg quantities.
GHRP-6 functions as a hexapeptide ghrelin receptor agonist and is used exclusively for in vitro and laboratory research applications. It is intended for research use only (RUO), not for human or veterinary use, and should be stored at –20 °C or below while protected from light, heat, and moisture.
Ipamorelin 10MG
Ipamorelin is a highly selective synthetic growth hormone secretagogue and a potent agonist of the ghrelin/growth hormone secretagogue receptor. It is a pentapeptide with a molecular weight of approximately 711.9 Da and is supplied as a white to off-white lyophilized powder with ≥99% HPLC research-grade purity.
Designed for laboratory research, Ipamorelin is used to study selective growth hormone release with minimal off-target activity. It is intended exclusively for in vitro and research applications and is not for human or veterinary use.
Ipamorelin/CJC-1295 (w/o DAC)
Ipamorelin/CJC-1295 (No DAC) 5MG/5MG is a synthetic peptide blend supplied as a white to off-white lyophilized powder for research use. The combination pairs a selective growth hormone secretagogue with a GHRH analogue, providing a stable tool for studying growth hormone signaling and release pathways in laboratory settings.
Ipamorelin supports targeted GH release without significant effects on cortisol or prolactin, while CJC-1295 (No DAC) enables precise evaluation of short-term hormonal responses due to its shorter half-life. Together, this blend allows researchers to investigate natural hormone patterns, metabolic function, and peptide interactions in controlled in vitro research applications.
Reviews
There are no reviews yet.